InfuSystem Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US45685K1025
USD
8.96
-0.38 (-4.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About InfuSystem Holdings, Inc. stock-summary
stock-summary
InfuSystem Holdings, Inc.
Miscellaneous
InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.
Company Coordinates stock-summary
Company Details
31700 Research Park Dr , MADISON HEIGHTS MI : 48071-4627
stock-summary
Tel: 1 248 29112101 602 8899700
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 33 Schemes (23.96%)

Foreign Institutions

Held by 25 Foreign Institutions (2.31%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Scott Shuda
Independent Chairman of the Board
Mr. Richard Diiorio
President, Chief Executive Officer, Director
Dr. Gregg Lehman
Vice Chairman of the Board
Mr. Paul Gendron
Independent Director
Mr. Darrell Montgomery
Independent Director
Mr. Christopher Sansone
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
36 Million
(Quarterly Results - Jun 2025)
Net Profit:
3 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 246 Million (Micro Cap)

stock-summary
P/E

47.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

9.30%

stock-summary
Price to Book

4.50